AP-Brain (3g)
Sponsors
Rousselot BVBA
Conditions
CognitionCognitive FunctionCognitive Performance
Unknown Phase
A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Performance at Varying Dosages in Healthy Middle-aged and Older Adults With Self-reported Memory Problems
RecruitingNCT07388043
Start: 2026-07-15End: 2026-11-01Target: 120Updated: 2026-09-18
A Clinical Trial to Investigate the Safety and Efficacy of AP-Brain on Cognitive Function at Varying Dosages in Healthy Younger Adults With Self-reported Attention Problems
RecruitingNCT07388576
Start: 2026-07-22End: 2026-11-01Target: 120Updated: 2026-09-18